Dr. Martens plc (LON:DOCS – Get Free Report) dropped 9.6% during trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares were traded during trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.
Wall Street Analyst Weigh In
Separately, Peel Hunt reissued a “buy” rating on shares of Dr. Martens in a report on Thursday. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of GBX 6,000.
Read Our Latest Stock Analysis on Dr. Martens
Dr. Martens Stock Performance
Dr. Martens (LON:DOCS – Get Free Report) last posted its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities research analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, insider Giles Wilson sold 30,000 shares of the business’s stock in a transaction on Monday, September 1st. The stock was sold at an average price of GBX 91, for a total transaction of £27,300. Also, insider Ije Nwokori sold 298,675 shares of the business’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50. In the last three months, insiders have purchased 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. Corporate insiders own 2.80% of the company’s stock.
Dr. Martens Company Profile
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Further Reading
- Five stocks we like better than Dr. Martens
- What Are Treasury Bonds?
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
- What is a Dividend King?
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
